Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder

被引:85
|
作者
Nixon, RG
Chang, SS
Lafleur, BJ
Smith, JA
Cookson, MS
机构
[1] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Div Biostat, Dept Prevent Med, Nashville, TN 37212 USA
来源
JOURNAL OF UROLOGY | 2002年 / 167卷 / 02期
关键词
urethra; cystectomy; carcinoma in situ; urothelium; carcinoma; transitional cell;
D O I
10.1016/S0022-5347(01)69073-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Determining which patients are at risk for prostatic urethral involvement of urothelial carcinoma may alter assessment of the prostatic urethra before radical cystectomy and ultimately influence the choice of urinary diversion, We determined risk factors predictive of prostatic urethral involvement using preoperative bladder tumor characteristics in male patients who underwent radical cystoprostatectomy due to urothelial carcinoma of the bladder. Materials and Methods: We reviewed 192 consecutive radical cystectomy specimens from men with transitional cell carcinoma from June 1995 to June 2000. The prostatic urethra in each specimen was analyzed and urethral involvement was characterized as carcinoma in situ, intraductal invasion or prostatic stromal invasion. We then examined which clinical bladder tumor characteristics correlated with the incidence and extent of prostatic urethral involvement by performing multiple variable analysis. Results: Prostatic urethral involvement was evident in 30 of the 192 patients (15.6%), Of the 80 patients with carcinoma in situ in the bladder 25 (31.3%) had concomitant prostatic urethral involvement with carcinoma, whereas only 5 (4.5%) of the 112 with no evidence of carcinoma in situ had prostatic urethral involvement. Likewise 25 of the 72 patients (34.7%) with multifocal tumors had concomitant prostatic urethral involvement with carcinoma, whereas only 5 (4.2%) of the 120 with no evidence of multifocality had prostatic urethral involvement. In the multiple variable logistic regression model the odds of prostatic urethral involvement were 12 and 15-fold greater when carcinoma in situ and tumor multifocality were present, respectively, Conclusions: Carcinoma in situ and/or tumor multifocality are valuable prognostic indicators of prostatic urethral involvement. However, in their absence prostatic urethral involvement was rare. Ultimately the extent of prostatic urethral involvement may influence decisions, such as the choice of urinary diversion and need for urethrectomy, in men undergoing radical cystectomy.
引用
收藏
页码:502 / 505
页数:4
相关论文
共 50 条
  • [22] Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder
    Hara, I
    Miyake, H
    Hara, S
    Gotoh, A
    Okada, H
    Arakawa, S
    Kamidono, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (01) : 14 - 18
  • [23] TRANSITIONAL CELL-CARCINOMA OF URETHRA IN MEN HAVING CYSTECTOMY FOR BLADDER CANCER
    SCHELLHAMMER, PF
    WHITMORE, WF
    JOURNAL OF UROLOGY, 1976, 115 (01): : 56 - 60
  • [24] Recurrent and metastatic canine urethral transitional cell carcinoma without bladder involvement
    Santos, M.
    Pereira, P. Dias
    Montenegro, L.
    Faustino, A. M. R.
    VETERINARY RECORD, 2007, 160 (16) : 557 - 558
  • [25] Involvement of the anterior urethra in male patients with transitional cell carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy
    Tobisu, K
    Kanai, Y
    Sakamoto, M
    Fujimoto, H
    Doi, N
    Horie, S
    Kakizoe, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (06) : 406 - 409
  • [26] Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors
    Sved, PD
    Gomez, P
    Nieder, AM
    Manoharan, M
    Kim, SS
    Soloway, MS
    BJU INTERNATIONAL, 2004, 94 (06) : 785 - 789
  • [27] Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder
    Raghavan, D
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (06) : 468 - 474
  • [28] PARTIAL CYSTECTOMY FOR TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    LINDAHL, F
    JORGENSEN, D
    EGVAD, K
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1984, 18 (02): : 125 - 129
  • [29] Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy
    Bianco, FJ
    Justa, D
    Grignon, DJ
    Sakr, WA
    Pontes, JE
    Wood, DP
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (04) : 290 - 294
  • [30] Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder
    Karakiewicz, Pierre I.
    Shariat, Shahrokh F.
    Palapattu, Ganesh S.
    Gilad, Amiel E.
    Lotan, Yair
    Rogers, Craig G.
    Vazina, Amnon
    Gupta, Amit
    Bastian, Patrick J.
    Perrotte, Paul
    Sagalowsky, Arthur I.
    Schoenberg, Mark
    Lerner, Seth P.
    JOURNAL OF UROLOGY, 2006, 176 (04): : 1354 - 1361